Demand for FDA Action Amid Shuffle

Demand for FDA Action Amid Shuffle

Demand for FDA Action Amid Shuffle Sarah Owermohle, Zachary Brennan and David Lim | Politico “The president’s executive order for CMS to finalize a rule eliminating rebates that drugmakers pay to pharmacy benefit managers had one big caveat — the rule cannot...